Top

Current Obstetrics and Gynecology Reports

Published in:

01-09-2014 | Pelvic Organ Prolapse (KL Noblett, Section Editor)

Recent Developments in the Non-surgical Management of Pelvic Organ Prolapse

Authors: Nèvine I. D. te West, Kate H. Moore

Published in: Current Obstetrics and Gynecology Reports | Issue 3/2014

Abstract

Pelvic organ prolapse is a common condition, although not always symptomatic. With the aging population and increased burden on the healthcare, non-surgical management of pelvic organ prolapse is becoming increasingly topical. Recent data show that prolapse appears to fluctuate over time. Regression is possible (3-40 %) and the risk of progression small (11-19 %). This review discusses the various nonsurgical options available, including observation, vaginal oestrogen, lifestyle modifications, physiotherapy, and vaginal ring pessaries. Although evidence from randomised, controlled trials is limited, these options should be discussed with women who do not desire, or are unfit for, surgery.

Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4–20.PubMed

Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JO, Klarskov P, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;175(1):10–7.PubMedCrossRef

Bradley CS, Zimmerman MB, Qi Y, Nygaard IE. Natural history of pelvic organ prolapse in postmenopausal women. Obstet Gynecol. 2007;109(4):848–54.PubMedCrossRef

Miedel A, Tegerstedt G, Maehle-Schmidt M, Nyren O, Hammarstrom M. Nonobstetric risk factors for symptomatic pelvic organ prolapse. Obstet Gynecol. 2009;113(5):1089–97.PubMedCrossRef

Jelovsek JE, Maher C, Barber MD. Pelvic organ prolapse. Lancet. 2007;369(9566):1027–38.PubMedCrossRef

Lince SL, van Kempen LC, Vierhout ME, Kluivers KB. A systematic review of clinical studies on hereditary factors in pelvic organ prolapse. Int Urogynecol J. 2012;23(10):1327–36.PubMedCentralPubMedCrossRef

Kerkhof MH, Hendriks L, Brolmann HA. Changes in connective tissue in patients with pelvic organ prolapse–a review of the current literature. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(4):461–74.PubMedCrossRef

Barber MD, Visco AG, Wyman JF, Fantl JA, Bump RC. Sexual function in women with urinary incontinence and pelvic organ prolapse. Obstet Gynecol. 2002;99(2):281–9.PubMedCrossRef

Jelovsek JE, Barber MD. Women seeking treatment for advanced pelvic organ prolapse have decreased body image and quality of life. Am J Obstet Gynecol. 2006;194(5):1455–61.PubMedCrossRef

10.

Samuelsson EC, Victor FT, Tibblin G, Svardsudd KF. Signs of genital prolapse in a Swedish population of women 20 to 59 years of age and possible related factors. Am J Obstet Gynecol. 1999;180(2 Pt 1):299–305.PubMedCrossRef

11.

Barber MD, Maher C. Epidemiology and outcome assessment of pelvic organ prolapse. Int Urogynecol J. 2013;24(11):1783–90.PubMedCrossRef

12.

Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A. Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol. 2002;186(6):1160–6.PubMedCrossRef

13.

Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89(4):501–6.PubMedCrossRef

14.

Miedel A, Tegerstedt G, Morlin B, Hammarstrom M. A 5-year prospective follow-up study of vaginal surgery for pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(12):1593–601.PubMedCrossRef

15.

Chen Z, Wong V, Wang A, Moore KH. Nine-year objective and subjective follow-up of the ultra-lateral anterior repair for cystocele. Int Urogynecol J. 2013.

16.

Boyles SH, Weber AM, Meyn L. Procedures for pelvic organ prolapse in the United States, 1979-1997. Am J Obstet Gynecol. 2003;188(1):108–15.PubMedCrossRef

17.

Population Division USCB. Projections of the Population by Age and Sex for the United States: 2010 to 2050.

18.

Bland DR, Earle BB, Vitolins MZ, Burke G. Use of the Pelvic Organ Prolapse staging system of the International Continence Society, American Urogynecologic Society, and Society of Gynecologic Surgeons in perimenopausal women. Am J Obstet Gynecol. 1999;181(6):1324–7. discussion 7-8.PubMedCrossRef

19.

Handa VL, Garrett E, Hendrix S, Gold E, Robbins J. Progression and remission of pelvic organ prolapse: a longitudinal study of menopausal women. Am J Obstet Gynecol. 2004;190(1):27–32.PubMedCrossRef

20.

Miedel A, Ek M, Tegerstedt G, Maehle-Schmidt M, Nyren O, Hammarstrom M. Short-term natural history in women with symptoms indicative of pelvic organ prolapse. Int Urogynecol J. 2011;22(4):461–8.PubMedCrossRef

21.•

Gilchrist AS, Campbell W, Steele H, Brazell H, Foote J, Swift S. Outcomes of observation as therapy for pelvic organ prolapse: a study in the natural history of pelvic organ prolapse. Neurourol Urodyn. 2013;32(4):383–6. A study on observational follow up of POP in women symptomatic for POP.PubMedCrossRef

22.

Haspels AA, Luisi M, Kicovic PM. Endocrinological and clinical investigations in post-menopausal women following administration of vaginal cream containing oestriol. Maturitas. 1981;3(3–4):321–7.PubMedCrossRef

23.

Griebling TL, Liao Z, Smith PG. Systemic and topical hormone therapies reduce vaginal innervation density in postmenopausal women. Menopauss (New York, NY). 2012;19(6):630–5.CrossRef

24.

Reay Jones NH, Healy JC, King LJ, Saini S, Shousha S, Allen-Mersh TG. Pelvic connective tissue resilience decreases with vaginal delivery, menopause and uterine prolapse. Br J Surg. 2003;90(4):466–72.PubMedCrossRef

25.

Ismail SI, Bain C, Hagen S. Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women. Cochrane Database Syst Rev. 2010;(9):Cd007063.

26.

Felding C, Mikkelsen AL, Clausen HV, Loft A, Larsen LG. Preoperative treatment with oestradiol in women scheduled for vaginal operation for genital prolapse. A randomised, double-blind trial. Maturitas. 1992;15(3):241–9.PubMedCrossRef

27.

Vardy MD, Lindsay R, Scotti RJ, Mikhail M, Richart RM, Nieves J, et al. Short-term urogenital effects of raloxifene, tamoxifen, and estrogen. Am J Obstet Gynecol. 2003;189(1):81–8.PubMedCrossRef

28.

Valente M, Dettori C, Feraudo E, Re ME. Pelvic floor: new therapeutic approach. Int Urogynaecol J. 2000;11(issue suppl1:s97):11916.

29.

Goldstein SR, Neven P, Zhou L, Taylor YL, Ciaccia AV, Plouffe L. Raloxifene effect on frequency of surgery for pelvic floor relaxation. Obstet Gynecol. 2001;98(1):91–6.PubMedCrossRef

30.

Vaccaro CM, Mutema GK, Fellner AN, Crisp CC, Estanol MV, Kleeman SD, et al. Histologic and cytologic effects of vaginal estrogen in women with pelvic organ prolapse: a randomized controlled trial. Female Pelvic Med Reconstr Surg. 2013;19(1):34–9.PubMedCrossRef

31.

Rachaneni S, Latthe P. Role of perioperative low dose vaginal oestrogens in improving the outcomes of pelvic organ prolapse surgery. Med Hypotheses. 2013;81(6):1015–6.PubMedCrossRef

32.

Kudish BI, Iglesia CB, Sokol RJ, Cochrane B, Richter HE, Larson J, et al. Effect of weight change on natural history of pelvic organ prolapse. Obstet Gynecol. 2009;113(1):81–8.PubMedCentralPubMedCrossRef

33.

Myers DL, Sung VW, Richter HE, Creasman J, Subak LL. Prolapse symptoms in overweight and obese women before and after weight loss. Female Pelvic MedReconstr Surg. 2012;18(1):55–9.

34.

Hagen S, Stark D. Conservative prevention and management of pelvic organ prolapse in women. Cochrane Database Syst Rev. 2011;(12):Cd003882.

35.

Hagen S, Stark D, Glazener C, Sinclair L, Ramsay I. A randomized controlled trial of pelvic floor muscle training for stages I and II pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(1):45–51.PubMedCrossRef

36.•

Hagen S, Stark D, Glazener C, Dickson S, Barry S, Elders A, et al. Individualised pelvic floor muscle training in women with pelvic organ prolapse (POPPY): a multicentre randomised controlled trial. Lancet. 2014;383(9919):796–806. A large, rigorous multicentre trial comparing pelvic floor muscle training for POP to lifestyle advice.PubMedCrossRef

37.

Hyland G, Hay-Smith J, Treharne G. Women's experiences of doing long-term pelvic floor muscle exercises for the treatment of pelvic organ prolapse symptoms. Int Urogynecol J. 2014;25(2):265–71.PubMedCrossRef

38.

Shah SM, Sultan AH, Thakar R. The history and evolution of pessaries for pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17(2):170–5.PubMedCrossRef

39.

Bugge C, Adams EJ, Gopinath D, Reid F. Pessaries (mechanical devices) for pelvic organ prolapse in women. Cochrane Database Systema Rev. 2013;2:Cd004010.

40.

Cundiff GW, Weidner AC, Visco AG, Bump RC, Addison WA. A survey of pessary use by members of the American urogynecologic society. Obstet Gynecol. 2000;95(6 Pt 1):931–5.PubMedCrossRef

41.•

Khaja A, Freeman RM. How often should shelf/Gellhorn pessaries be changed? A survey of IUGA urogynaecologists. International urogynecology journal. Published online 15th February 2014. An interesting survey on the variety of use and follow up of shelf and Gellhorn pessaries amongst urogyanecologists.

42.

Lone F, Thakar R, Sultan AH, Karamalis G. A 5-year prospective study of vaginal pessary use for pelvic organ prolapse. Int J Gynaecol Obstet: Off Org Int Fed Gynaecol Obstet. 2011;114(1):56–9.CrossRef

43.

Fernando RJ, Thakar R, Sultan AH, Shah SM, Jones PW. Effect of vaginal pessaries on symptoms associated with pelvic organ prolapse. Obstet Gynecol. 2006;108(1):93–9.PubMedCrossRef

44.

Handa VL, Jones M. Do pessaries prevent the progression of pelvic organ prolapse? Int Urogynecol J Pelvic Floor Dysfunct. 2002;13(6):349–51. discussion 52.PubMedCrossRef

45.

Patel M, Mellen C, O'Sullivan DM, LaSala CA. Impact of pessary use on prolapse symptoms, quality of life, and body image. Am J Obstet Gynecol. 2010;20(5):499.e1-4.

46.

Abdool Z, Thakar R, Sultan AH, Oliver RS. Prospective evaluation of outcome of vaginal pessaries versus surgery in women with symptomatic pelvic organ prolapse. Int Urogynecol J. 2011;22(3):273–8.PubMedCrossRef

47.

Clemons JL, Aguilar VC, Tillinghast TA, Jackson ND, Myers DL. Risk factors associated with an unsuccessful pessary fitting trial in women with pelvic organ prolapse. Am J Obstet Gynecol. 2004;190(2):345–50.PubMedCrossRef

48.

Singh K, Reid WM. Non-surgical treatment of uterovaginal prolapse using double vaginal rings. BJOG: Int J Obstet Gynaecol. 2001;108(1):112–3.

49.

Kenton K, Barber M, Wang L, Hsu Y, Rahn D, Whitcomb E, et al. Pelvic floor symptoms improve similarly after pessary and behavioral treatment for stress incontinence. Female Pelvic Med Reconstr Surg. 2012;18(2):118–21.PubMedCentralPubMedCrossRef

50.

Moore KH, Foote A, Siva S, King J, Burton G. The use of the bladder neck support prosthesis in combined genuine stress incontinence and detrusor instability. Aust New Zealand J Obstet Gynaecol. 1997;37(4):440–5.CrossRef

51.

Moore KH, Foote A, Burton G, King J. An open study of the bladder neck support prosthesis in genuine stress incontinence. Br J Obstet Gynaecol. 1999;106(1):42–9.PubMedCrossRef

52.

Arias BE, Ridgeway B, Barber MD. Complications of neglected vaginal pessaries: case presentation and literature review. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(8):1173–8.PubMedCrossRef

53.

Sarma S, Ying T, Moore KH. Long-term vaginal ring pessary use: discontinuation rates and adverse events. BJOG: Int J Obstet Gynaecol. 2009;116(13):1715–21.CrossRef

Title: Recent Developments in the Non-surgical Management of Pelvic Organ Prolapse
Authors: Nèvine I. D. te West
Kate H. Moore
Publication date: 01-09-2014
Publisher: Springer US
Published in: Current Obstetrics and Gynecology Reports / Issue 3/2014
Electronic ISSN: 2161-3303
DOI: https://doi.org/10.1007/s13669-014-0087-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Recent Developments in the Non-surgical Management of Pelvic Organ Prolapse

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2014

Erratum to: Update of Conservative Systemic Treatment of Uterine Fibroids

Update of Conservative Systemic Treatment of Uterine Fibroids

An Evidence-Based Approach to the Evaluation, Diagnostic Assessment, and Treatment of Fecal Incontinence in Women

Surgical Treatment of Fibroids

The Past, Present and Future of POP and Physical Therapy

Role and Risks of Morcellation Associated with Laparoscopic Management of Myomas